Skip links


Research sheds light on Ethiopia’s condom market

Original research by DKT Ethiopia points to the strength of the organization’s two brands – Sensation and Hiwot Trust – in the private sector in Ethiopia. Over 90% of respondents in a 20-town survey of 1,100 current condom users are using a DKT brand condom. Among these, nearly three-fourths

Sensation Xtra makes mark across Ethiopia

Sensation Xtra, DKT’s new brand extension, is now available in outlets throughout Ethiopia. “We introduced Sensation Xtra nationally in early September and it’s now available in all regions,” says Negussie GebreTsadik, DKT Ethiopia’s National Operations Director. “We’re excited to continue the success of Sensation while

DKT Ethiopia awarded 22 best performing partner clinics

DKT Ethiopia awarded 22 best performing partner clinics for generating the highest CYP. DKT Ethiopia provided 520 face shields for its partner clinics. The face shields, distributed to 104 clinics working in partnership with DKT, are aimed at intensifying COVID-19 prevention in health institutions providing

Partner clinics – a growing source of reliable family planning

DKT Ethiopia’s foray into family planning service is meeting with success. The organization’s Partner Clinic model, which seeks to improve FP coverage and utilization in the private sector, is a hybrid product distribution and service delivery network started in May 2015 with 5 private clinics.

2015/16: A year of sustained output for DKT Ethiopia

DKT Ethiopia distributed 54 million condoms, 4.5 million cycles of oral contraceptives, 3.6 million injectable contraceptives, and 2.6 million emergency contraceptives, among other products, from July 2015 – June 2016. Together, DKT’s product distribution amounted to 3.2 million CYP. Servicing 15,000 pharmaceutical and clinical outlets on

HIV/AIDS- No time to let up

With the global incidence of HIV leveling off and even increasing in some areas, a concerted effort is required to sustain gains. Ethiopia’s success in dealing with HIV/AIDS is one of the shining examples globally. From 1999 to 2015, prevalence decreased from 3.4% to 1.2%,